KLEMP WALTER V bought MBRX
June 22, 2024 · Form 4 insider transaction
KLEMP WALTER V bought 8,990 shares of Moleculin Biotech, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,990
Price
N/A
Total value
N/A
InsiderKLEMP WALTER V
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 22, 2024
Filing dateJune 25, 2024
Shares owned after58,483
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.